Therapy-related myelodysplastic syndromes.
This article summarizes the clinical aspects, cytogenetics, and initiating agents associated with therapy-related myelodysplastic syndromes. Details regarding associated chemotherapeutic agents and ionizing radiation are discussed and therapeutic considerations are presented.
Rosenbloom
B
B
Department of Medicine, Cedars-Sinai Medical Center, Los Angeles, California.
Schreck
R
R
Koeffler
H P
HP
D000970:Antineoplastic Agents / Q000009:adverse effects*; D006801:Humans; D009190:Myelodysplastic Syndromes / Q000139:chemically induced / Q000209:etiology* / Q000235:genetics; D011878:Radiotherapy / Q000009:adverse effects*; D012307:Risk Factors
D000970:Antineoplastic Agents